Lansdowne Partners Healthcare News

This is selected healthcare news for Lansdowne Partners, which is filed under Capital Firms. There are 244 news items for this page.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source
9/10/2022 31,000 Shares in Moderna, Inc. (NASDAQ:MRNA) Acquired by Lansdowne Partners UK LLP
Lansdowne Partners UK LLP bought a new position in shares of Moderna, Inc. ( NASDAQ:MRNA ‚Ai Get Rating ) in the 1st quarter, Holdings Channel reports. The fund bought 31,000 shares of the company's stock, valued at approximately $5,340,000. Moderna accounts for 0.4% of Lansdowne Partners UK LLP's portfolio ...
The Markets Daily
7/25/2022 Replay Launches with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA
... biology by writing and delivering big DNA, today announced its launch with $55 million in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay's portfolio of next-generation genomic medicine technologies aims ...
Yahoo News
7/25/2022 Replay Launches with $55 Million Seed to Reprogram Biology by Writing and Delivering Big DNA
... biology by writing and delivering big DNA, today announced its launch with $55 million in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay's portfolio of next-generation genomic medicine technologies aims ...
Globe Newswire
7/25/2022 Replay launches with $55M to reprogram biology by writing and delivering big DNA
Replay, a genome writing company reprogramming biology by writing and delivering big DNA, has launched with $55 million in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay, which is based in San ...
labiotech.eu
7/25/2022 Replay Launches with $55 Million Seed to Reprogram Biology
... biology by writing and delivering big DNA, today announced its launch with $55 million in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay's portfolio of next-generation genomic medicine technologies aims ...
Globe Newswire
7/17/2022 Investor in Oxford University spin-offs raises £215m shepherdgazette.com
5/26/2022 EXCLUSIVE: Moa nets $44m Series B funding to launch the next generation of herbicides agfundernews.com
5/24/2022 Illumina, Inc. (NASDAQ:ILMN) Position Boosted by Lansdowne Partners UK LLP rivertonroll.com
5/24/2022 Lansdowne Partners UK LLP Raises Stock Position in Illumina, Inc. (NASDAQ:ILMN) - Slater Sentinel slatersentinel.com
5/24/2022 Lansdowne Partners UK LLP Cuts Position in Analog Devices, Inc. (NASDAQ:ADI) dispatchtribunal.com
10/16/2021 Lansdowne Partners UK LLP Makes New $108.77 Million Investment in Illumina, Inc. (NASDAQ:ILMN) theenterpriseleader.com
8/18/2021 Lansdowne Partners (uk) Llp Buys Illumina Inc, Eaton Corp PLC, Warner Music Group Corp, Sells … google.com
8/17/2021 Lansdowne Partners (uk) Llp Buys Illumina Inc, Eaton Corp PLC, Warner Music Group Corp, Sells … gurufocus.com
7/11/2020 Weekly Commentary: Utmost Crazy blogspot.com
7/11/2020 Doug Noland’s Credit Bubble Bulletin: Utmost Crazy wallstreetexaminer.com
7/11/2020 July 10, 2020: Utmost Crazy mwealthm.com
5/11/2020 Opalesque Exclusive: The Corona Fighters Report 26: Asset managers who delivered in the downturn opalesque.com